Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma

NCT00737438 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Gastric Cancer

Interventions

DRUG: epirubicin, cisplatin, capecitabine, bevacizumab, docetaxel and irinotecan

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]